8-KItem 8.01 · Other EventsItem 9.01 · Financial Statements
Abbott ($ABT) closed its acquisition of Exact Sciences ($EXAS) on Mar 23, 2026.
Filed with the SEC on · Summarized by InvestorsBot
Abbott ($ABT) closed its acquisition of Exact Sciences ($EXAS) on Mar 23, 2026. Merger Sub merged into Exact; Exact is now a direct, wholly owned subsidiary of Abbott. 🤝🔬 #M&A #Healthcare
Under the Merger Agreement dated Nov 19, 2025, each outstanding Exact Sciences share converted into $105.00 cash (no interest), subject to applicable withholding taxes. $ABT $EXAS 💵 #M&A #Investing
Abbott filed the Merger Agreement as Exhibit 2.1 and a press release announcing the closing as Exhibit 99.1 in the 8‑K (filed Mar 23, 2026). Review exhibits for full terms. $ABT 📄 #SEC #Investing